the

The voice of passengers: these are the best airports for customer experience, ACI World reveals

The 2025 ASQ Customer Experience Awards show airports outperforming other industries as passenger satisfaction continues to riseMONTREAL, Feb. 24, 2026…

1 week ago

Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026

February 23, 2026 17:10 ET  | Source: Kyntra Bio FG-3246 and enzalutamide combination therapy, in biomarker unselected patients with androgen…

1 week ago

Versos AI Launches the First End-to-End Solution for Preparing and Licensing Video Training Data for AI

SAINT JOHN, New Brunswick, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Versos AI Inc. today announced the launch of the Video…

1 week ago

Denmark Street Icon Regent Sounds, Announces Exclusive Online Sale of T-Bone Walker’s Legendary 1949 Gibson ES-5N: “The Guitar That Started It All” on Reverb

LONDON, Feb. 23, 2026 /PRNewswire/ -- The newly reopened Regent Sounds guitar shop on Denmark Street will mark the launch…

1 week ago

Mumbai Climate Week Launches the People’s Climate Dictionary to Make Climate Language More Accessible

MUMBAI, India, Feb. 23, 2026 /PRNewswire/ -- At Mumbai Climate Week, a new public resource — the People's Climate Dictionary — was…

1 week ago

Gyder Surgical announces first commercial surgical cases in the United States performed by Dr. Paul M. Lombardi, M.D., at the Tri-County Orthopedics Joint Replacement Institute outpatient center

PALO ALTO, Calif. and MULGRAVE, Australia, Feb. 22, 2026 (GLOBE NEWSWIRE) -- Gyder Surgical, a MedTech company specializing in intuitive, non-invasive…

1 week ago

Dassault Systmes CEO Pascal Daloz becomes also Chairman of the Board of Directors of Dassault Systmes

Press ReleaseVELIZY-VILLACOUBLAY, France — February 21, 2026 Dassault Systèmes’ CEO Pascal Daloz becomes also Chairman of the Board of Directors…

2 weeks ago

U.S. Food and Drug Administration (FDA) Accepts Tevas New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-‘749) for the Once-Monthly Treatment of Schizophrenia in Adults

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If…

2 weeks ago

VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025

February 20, 2026 19:11 ET  | Source: VERSES AI Inc. VANCOUVER, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- VERSES…

2 weeks ago

Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results

February 20, 2026 17:16 ET  | Source: Constellation Software Inc. TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Constellation Software Inc.…

2 weeks ago